zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2009-6-3-5zdor-846Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEАНАЛИЗ КЛИНИКО-МОРФОЛОГИЧЕСКИХ ПАРАМЕТРОВ ПРИ РАЗВИТИИ РАННИХ РЕЦИДИВОВ У ПАЦИЕНТОВ С ПЕРВИЧНО- ОПЕРАБЕЛЬНЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫANALYSIS OF CLINICAL-MORPHOLOGICAL INDICATORS AT DEVELOPMENT OF EARLY RELAPSES IN PATIENTS WITH INITIALLY OPERABLE BREAST CANCERНадыровЭ. А.NadyrovE. A.noemail@neicon.ruРеспубликанский научно-практический центр радиационной медицины и экологии человекаRepublican Research Center for Radiation Medicine and Human Ecology200928092009032629Copyright © Надыров Э.А., 20092009Надыров Э.А.Nadyrov E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/846

Изучены основные клинико-диагностические показатели при различных исходах рака молочной железы. Показано, что раннее прогрессирование заболевания (до 3-х лет) определяется размерами опухоли, метастатическим поражением лимфатических узлов, высокой гистологической степенью злокачественности, возрастом на момент заболевания, а также комбинацией рецепторов половых гормонов.

We studied the major clinical-diagnostic indicators with different clinical outcomes of breast cancer. We show that early disease progression (up to 3 years) is defined by tumor size, lymph nodes metastases, high histological degree of malignancy, age at the moment of disease, as well as the combination of sex hormone receptors.

рак молочной железыпрогрессия заболеванияклинические и диагностические маркерыbreast cancerdisease progressionclinical and diagnostic markersReferencesEarly Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials / M. Clarke [et al.] // Lancet. - 2005. - Vol. 366, № 9503. - P. 2087-2106.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials / M. Clarke [et al.] // Lancet. - 2005. - Vol. 366, № 9503. - P. 2087-2106.Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is «young»? / J. L. Oh [et al.] // Int. J. Radiat. Oncol. Biol. Phys. - 2006. - Vol. 65, № 5. - P. 1345-1352.The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is «young»? / J. L. Oh [et al.] // Int. J. Radiat. Oncol. Biol. Phys. - 2006. - Vol. 65, № 5. - P. 1345-1352.Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials / A. Taghian [et al.] // J. Clin. Oncol. - 2004. - Vol. 15. - P. 4247-4254.Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials / A. Taghian [et al.] // J. Clin. Oncol. - 2004. - Vol. 15. - P. 4247-4254.Летягин, В. П. Органосохраняющие операции в комплексном лечении больных раком молочной железы / В. П. Летягин, Н. Н. Волченко // Рос. онкол. журн. - 2001. - № 4. - С. 4-6.Летягин, В. П. Органосохраняющие операции в комплексном лечении больных раком молочной железы / В. П. Летягин, Н. Н. Волченко // Рос. онкол. журн. - 2001. - № 4. - С. 4-6.Breast conservation after neoadjuvant chemotherapy: The M. D. Anderson cancer center experience / A. M. Chen [et al.] // J. Clin. Oncol. - 2004. - Vol. 22. - P. 2303-2312.Breast conservation after neoadjuvant chemotherapy: The M. D. Anderson cancer center experience / A. M. Chen [et al.] // J. Clin. Oncol. - 2004. - Vol. 22. - P. 2303-2312.Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.Dinshaw, K. A. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy / K. A. Dinshaw, A. N. Budrukkar, R. F. Chinoy // Int. J. Radiat. Oncol. Biol. Phys. - 2005. - Vol. 63, № 4. - P. 1132-1141.Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy / P. T. Truong [et al.] // J. Am. Coll. Surg. - 2005. - Vol. 2000, № 6. - P. 912-921.Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy / P. T. Truong [et al.] // J. Am. Coll. Surg. - 2005. - Vol. 2000, № 6. - P. 912-921.Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII / A. Wallgren [et al.] // J. Clin. Oncol. - 2003. - Vol. 21, № 7. - P. 1205-1213.Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII / A. Wallgren [et al.] // J. Clin. Oncol. - 2003. - Vol. 21, № 7. - P. 1205-1213.Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases / V. J. Bardou [et al.] // J. Clin. Oncol. - 2003. - Vol. 21. - P. 1973-1979.Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases / V. J. Bardou [et al.] // J. Clin. Oncol. - 2003. - Vol. 21. - P. 1973-1979.Estrogen receptor positive (ER+), progesterone receptor negative (PgR-) breast cancer: new insights into molecular mechanisms and clinical implications / G. Arpino [et al.] // Breast cancer research and treatment. 27Ih Annual San Antonio breast cancer symposium. - 2004. - Vol. 88. - Р. 105.Estrogen receptor positive (ER+), progesterone receptor negative (PgR-) breast cancer: new insights into molecular mechanisms and clinical implications / G. Arpino [et al.] // Breast cancer research and treatment. 27Ih Annual San Antonio breast cancer symposium. - 2004. - Vol. 88. - Р. 105.Божок, А. А. Прогностические и предсказующие факторы при раке молочной железы / А. А Божок. // Матер. IV междунар. ежегодной конф. «Проблемы диагностики и лечения рака молочной железы». - М., 2007. - С. 26Божок, А. А. Прогностические и предсказующие факторы при раке молочной железы / А. А Божок. // Матер. IV междунар. ежегодной конф. «Проблемы диагностики и лечения рака молочной железы». - М., 2007. - С. 26

The authors declare that there are no conflicts of interest present.